Pemphigus herpetiformis
{{see also|List of target antigens in pemphigus}}
{{Infobox medical condition (new)
| name =
| synonym = Acantholytic herpetiform dermatitis, Herpetiform pemphigus, Mixed bullous disease, Pemphigus controlled by sulfapyridine
| image =
| image_size =
| alt =
| caption =
| pronounce =
| specialty = dermatology
| symptoms =
| complications =
| onset =
| duration =
| types =
| causes =
| risks =
| diagnosis =
| differential =
| prevention =
| treatment =
| medication =
| prognosis =
| frequency =
| deaths =
}}
Pemphigus herpetiformis is a cutaneous condition, a clinical variant of pemphigus that combines the clinical features of dermatitis herpetiformis with the immunopathologic features of pemphigus.{{cite book |author=Rapini, Ronald P. |author2=Bolognia, Jean L. |author3=Jorizzo, Joseph L. |title=Dermatology: 2-Volume Set |publisher=Mosby |location=St. Louis |year=2007 |isbn=978-1-4160-2999-1 }}
Pathophysiology
Pemphigus Herpetiformis is an IGg mediated autoantibodies that affect the epidermal layer of the skin.{{Cite journal|last = Sandhu|first = Neil|others = Neil Sandhu, MD Dermatologist (Medical/Cosmetics) and Mohs Surgeon, Gulf Coast Dermatology|title = Pemphigus Herpetiformis: Background, Pathophysiology, Epidemiology|url = http://emedicine.medscape.com/article/1064550-overview#a5|date = 2019-01-09}}
Diagnosis
{{Empty section|date=July 2018}}